Ata uhi

Clinical study on blood routine and dynamic changes, condition and prognosis of hand foot and mouth disease (EV71)

<p>Objective: To explore the relationship between the total number of white blood cells and the ratio of neutrophils to lymphocytes in the blood of hand-foot-mouth disease (EV71) and the condition of the disease, and to explore the relationship between the dynamic changes of blood samples abov...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Ling-liang Yao (Author), Le Kang (Author)
Hōputu:	Pukapuka
I whakaputaina:	Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications, 2021-04-20.
Ngā marau:	Research Article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

EV71 vaccination impact on the incidence of encephalitis in patients with hand, foot and mouth disease
mā: Jian Li, me ētahi atu.
I whakaputaina: (2021)

Epidemiological characteristics of hand, foot and mouth disease in Shenzhen from 2008 to 2020 and effect of inactivated EV71 vaccine on disease incidence
mā: Zhao-yi LIANG, me ētahi atu.
I whakaputaina: (2023)

Chinese parents' intention to vaccinate their 0-5-year-old children with the EV-71 vaccine against hand, foot, and mouth disease and willingness-to-pay
mā: Lu Cheng, me ētahi atu.
I whakaputaina: (2024)

Massive pulmonary hemorrhage in enterovirus 71-infected hand, foot, and mouth disease
mā: Dong Seong Lee, me ētahi atu.
I whakaputaina: (2015)

Impact of the launch of EV71 vaccination on prevalence characteristics and pathogen spectrum of severe hand, foot and mouth disease in Henan province, 2014 - 2020: a register data analysis
mā: Ruolin WANG, me ētahi atu.
I whakaputaina: (2024)

Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
mā: Yueh-Liang Tsou, me ētahi atu.
I whakaputaina: (2015)

Cyclical Patterns of Hand, Foot and Mouth Disease Caused by Enterovirus A71 in Malaysia.
mā: Nmn NikNadia, me ētahi atu.
I whakaputaina: (2016)

Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines
mā: Weijian Zhang, me ētahi atu.
I whakaputaina: (2020)

Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China
mā: Xiaoli Wang, me ētahi atu.
I whakaputaina: (2019)

DNA methylation and single-nucleotide polymorphisms in DDX58 are associated with hand, foot and mouth disease caused by enterovirus 71.
mā: Ya-Ping Li, me ētahi atu.
I whakaputaina: (2022)

Enterovirus 71-associated hand, foot and mouth diseases with neurologic symptoms, a university hospital experience in Korea, 2009
mā: Hye Kyung Cho, me ētahi atu.
I whakaputaina: (2010)

Classical Hand, Foot and Mouth Disease Replaced by Atypical Hand, Foot and Mouth Disease
mā: Regina Fölster-Holst
I whakaputaina: (2018)

A case report of a teenager with severe hand, foot, and mouth disease with brainstem encephalitis caused by enterovirus 71
mā: Ying-Fu Chen, me ētahi atu.
I whakaputaina: (2019)

Hand, foot and mouth disease
mā: Radhika Muppa, me ētahi atu.
I whakaputaina: (2011)

Effectiveness of Enterovirus 71 inactivated vaccines against hand, foot, and mouth disease: A test-negative case-control study
mā: Yutong Zhang, me ētahi atu.
I whakaputaina: (2024)

Dermoscopy of hand, foot, and mouth disease
mā: Hitaishi Mehta, me ētahi atu.
I whakaputaina: (2023)

Hand, foot, and mouth disease in an infant
mā: Sandra Caridad Laurencio Vallina, me ētahi atu.
I whakaputaina: (2019)

Seroprevalence of EV-A71 neutralizing antibodies following the 2011 epidemic in HCMC, Vietnam.
mā: Fang-Lin Kuo, me ētahi atu.
I whakaputaina: (2020)

Berberine prevents lethal EV71 neurological infection in newborn mice
mā: Guangyi Cui, me ētahi atu.
I whakaputaina: (2022)

Antiviral activity of silymarin in comparison with baicalein against EV-A71
mā: Salima S. Lalani, me ētahi atu.
I whakaputaina: (2020)

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris
mā: Zhijian Yang, me ētahi atu.
I whakaputaina: (2020)

Onychomadesis due to hand-foot-mouth disease
mā: Patricia Chang, me ētahi atu.
I whakaputaina: (2019)

Foot, hand and mouth disease. Case presentation
mā: Deyanira Cabrera Escobar, me ētahi atu.
I whakaputaina: (2018)

Foot, hand and mouth disease. Case presentation
mā: Deyanira Cabrera Escobar, me ētahi atu.
I whakaputaina: (2018)

Outbreak of hand, foot, and mouth disease in Udaipur
mā: Nidheesh Agarwal, me ētahi atu.
I whakaputaina: (2015)

The need for development of other enterovirus vaccines in addition to EV-A71 vaccine
mā: Daoyan Xu, me ētahi atu.
I whakaputaina: (2024)

Gambaran Klinis dan Karakteristik Genetik Human Enterovirus 71 Penyebab Hand Foot and Mouth Disease di Banjarmasin - Kalimantan Selatan Tahun 2016
mā: Edi Hartoyo
I whakaputaina: (2020)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
mā: Hui Xuan Lim, me ētahi atu.
I whakaputaina: (2019)

Evaluation and mechanism study of Pien Tze Huang against EV-A71 infection
mā: Huiqiang Wang, me ētahi atu.
I whakaputaina: (2023)

Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation
mā: Yuemei Hu, me ētahi atu.
I whakaputaina: (2018)

Analysis of the etiological characteristics of hand-foot-mouth disease in 3 193 cases
mā: Jin-ling FU, me ētahi atu.
I whakaputaina: (2020)

Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014
mā: Xin Yao, me ētahi atu.
I whakaputaina: (2017)

Relapse of hand foot and mouth disease: Are we at more risk?
mā: Nilendu Sarma
I whakaputaina: (2013)

Hand, Foot and Mouth disease in northeastern part of Romania in 2012
mā: Anca Chiriac, me ētahi atu.
I whakaputaina: (2013)

A case of onychomadesis following Hand, Foot, and Mouth disease
mā: Hristo Dobrev, me ētahi atu.
I whakaputaina: (2016)

Association of neighborhood greenness with severity of hand, foot, and mouth disease
mā: Zhicheng Du, me ētahi atu.
I whakaputaina: (2022)

An atypical manifestation of hand-foot and mouth disease involving the genitalia
mā: Bharathi Ravikumar, me ētahi atu.
I whakaputaina: (2021)

Detection of hand, foot and mouth disease in the Yucatan Peninsula of Mexico
mā: Carlos Machain-Williams, me ētahi atu.
I whakaputaina: (2014)

An evaluation of a test-negative design for EV-71 vaccine from a randomized controlled trial
mā: Li Zhang, me ētahi atu.
I whakaputaina: (2021)

Acute pancreatitis in hand, foot and mouth disease caused by Coxsackievirus A16: case report
mā: Byungsung Park, me ētahi atu.
I whakaputaina: (2017)